|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory for Physiology, Institute for Cardiovascular Research (ICaR-VU), VU University, Amsterdam, The Netherlands
2 Facultad de Ciencias Medicas de La Plata, Centro de Investigaciones Cardiovasculares, La Plata, Argentina
* To whom correspondence should be addressed. E-mail: Lamberts{at}physiol.med.vu.nl.
Collagen degradation is suggested to be responsible for long-term contractile dysfunction in different cardiomyopathies, but the effects of acute and specific collagen type I removal (main type in the heart muscle) on tension have not been studied. We determined diastolic and developed tension-length relations in isometric contracting perfused rat papillary muscles (perfusion pressure 60 cm H2O) before and after acute and specific removal of small collagen-struts using purified collagenase type I. At 95%Lmax, diastolic tension increased 20.4 ± 8.1% (p<0.05, n=6) and developed tension increased 15.0 ± 6.7% after collagenase treatment compared to time-controls. Treatment increased the diastolic muscle diameter by 7.1 ± 3.4% at 95%Lmax, whereas the change in diameter due to contraction was not changed. Diastolic coronary flow and normalized coronary arterial flow impediment did not changed after collagenase treatment. Electron microscopy revealed that the number of small collagen-struts, interconnecting myocytes and capillaries, was reduced to ~32% after treatment. We conclude that removal of the small collagen struts by acute and specific collagen type I degradation increases diastolic and developed tension in perfused papillary muscle. We suggest that diastolic tension is increased due to edema, while developed tension is increased because the removal of the struts poses a lower lateral load on the cardiac myocytes, allowing more myocyte thickening.
This article has been cited by other articles:
![]() |
M. J. Overbeek, J-W. Lankhaar, N. Westerhof, A. E. Voskuyl, A. Boonstra, J. G. F. Bronzwaer, K. M. J. Marques, E. F. Smit, B. A. C. Dijkmans, and A. Vonk-Noordegraaf Right ventricular contractility in systemic sclerosis-associated and idiopathic pulmonary arterial hypertension Eur. Respir. J., June 1, 2008; 31(6): 1160 - 1166. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Brower, J. D. Gardner, M. F. Forman, D. B. Murray, T. Voloshenyuk, S. P. Levick, and J. S. Janicki The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur. J. Cardiothorac. Surg., October 1, 2006; 30(4): 604 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Westerhof, C. Boer, R. R. Lamberts, and P. Sipkema Cross-talk between cardiac muscle and coronary vasculature. Physiol Rev, October 1, 2006; 86(4): 1263 - 1308. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Knaapen, M. J. W. Gotte, W. J. Paulus, J. J. M. Zwanenburg, P. A. Dijkmans, R. Boellaard, J. T. Marcus, J. W. R. Twisk, C. A. Visser, A. C. van Rossum, et al. Does Myocardial Fibrosis Hinder Contractile Function and Perfusion in Idiopathic Dilated Cardiomyopathy? PET and MR Imaging Study. Radiology, August 1, 2006; 240(2): 380 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. Walker, M. B. Ratcliffe, P. Zhang, A. W. Wallace, B. Fata, E. W. Hsu, D. Saloner, and J. M. Guccione MRI-based finite-element analysis of left ventricular aneurysm Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H692 - H700. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Sarin, R. D Gaffin, G. A Meininger, and M. Muthuchamy Arginine-glycine-aspartic acid (RGD)-containing peptides inhibit the force production of mouse papillary muscle bundles via {alpha}5{beta}1 integrin J. Physiol., April 15, 2005; 564(2): 603 - 617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |